Posts filed under: Vascular Access

Demand for port access needles, midline and extended-dwell peripheral catheters, ultrasound systems for vascular access, and catheter securement devices is driving growth....
Continue Reading →
  • POWERWAND™ CVC vascular access device
The POWERWAND CVC, in addition to being high-flow and rapidly inserted, is also power-injectable at 8ml/sec. — allowing even the most challenging contrast CT studies to be completed using the device....
Continue Reading →
The Angel® Catheter met all safety endpoints and demonstrated a significant reduction in clinically significant and fatal pulmonary embolism (PE)....
Continue Reading →
New technologies are expected to have a significant impact on the vascular access device market in Australia....
Continue Reading →
The increasing prevalence of diseases and conditions that require long-term vascular access is driving innovation and the increased use of vascular access devices in Australia....
Continue Reading →
The increasing prevalence of diseases and conditions that require long-term vascular access is fueling the increased use of vascular access devices and is expected to be a driving factor in the Japanese market...
Continue Reading →
The syringe and needle segment is experiencing different growth trends. The Europe market for syringes and needles is expected to reach over €675 million by 2023 due to a strong shift towards the use of more expensive safety needles....
Continue Reading →
The Europe market for vascular access devices and accessories is expected to increase to reach over €1 billion by 2023. Europe-wide legislation promoting the use of safety devices such as syringes and needles in the workplace has resulted in market...
Continue Reading →
The U.S. market for vascular access devices and accessories will grow to reach a market value of just over $5 billion by 2022. Market growth will be driven by government policies that encourage safer practices and products....
Continue Reading →
Register to receive a free US Peripheral Vascular Device Market – 2016 report synopsis and brochure W.L. Gore recently announced the U.S. Food and Drug Administration (FDA) approval of the GORE® TIGRIS® Vascular Stent, a dual-component stent with a fluoropolymer...
Continue Reading →

Thank you!

CLOSE

Login

Sign Up

Already have an account? Sign in

×